abexinostat,
CRA 024781,
CRA-024781,
CRA024781,
PCI 24781,
PCI-24781,
PCI24781,
PCI-24781,
783355-60-2,
ABEXINOSTAT,
CRA-024781,
PCI 24781,
CRA 024781,
CRA-02478,
Abexinostat (PCI-24781),
UNII-IYO470654U,
3-((dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)benzofuran-2-carboxamide,
Abexinostat(PCI-24781),
PCI-24781 (CRA-024781),
IYO470654U,
CRA 24781,
3-[(Dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide,
3-((Dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)-phenoxy)ethyl)benzofuran-2-carboxamide,
3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide,
Abexinostat [USAN:INN],
3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide,
PCI24781,
Abexinostat (USAN),
MLS006011097,
SCHEMBL444280,
PCI-24781 (Abexinostat),
GTPL8366,
CHEMBL2103863,
BDBM24622,
CHEBI:92223,
DTXSID30229005,
QCR-135,
MAUCONCHVWBMHK-UHFFFAOYSA-N,
BCPP000128,
HMS3654A19,
EX-A2123,
KS-00001CU4,
ZINC6716700,
ABP000146,
FD5037,
MFCD10565969,
s1090,
AKOS025149423,
API0005168,
BCP9001054,
CS-0478,
DB12565,
RL05036,
SB16670,
NCGC00346486-01,
NCGC00346486-05,
AC-26866,
BC660002,
HY-10990,
SMR004702885,
PCI-24781 (Synonyms CRA-02478),
AB0008056,
DB-075461,
PCI-24781,CRA-024781,
PCI-24781/CRA-02478/,
FT-0673532,
SW218266-2,
X7604,
EC-000.2348,
A10700,
D10060,
S-7785,
S78454,
S-78454,
J-511438,
BRD-K12867552-001-01-3,
CRA-02478, 783355-60-2,
3-(dimethylaminomethyl)-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide,
2-Benzofurancarboxamide, 3-((dimethylamino)methyl)-N-(2-(4-((hydroxyamino)carbonyl)phenoxy)ethyl)-,
Abexinostat [USAN],
D0V0SL,
cc-488,
C21H23N3O5,
CRA024781,
CID11749858,
A4098,
C512352,
3-(dimethylaminomethyl)-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]benzofuran-2-carboxamide,